| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | procollagen-proline 3-dioxygenase activity | 1.23e-05 | 3 | 41 | 2 | GO:0019797 | |
| GeneOntologyMolecularFunction | peptidyl-proline 3-dioxygenase activity | 2.46e-05 | 4 | 41 | 2 | GO:0031544 | |
| GeneOntologyMolecularFunction | procollagen-proline dioxygenase activity | 1.14e-04 | 8 | 41 | 2 | GO:0019798 | |
| GeneOntologyMolecularFunction | peptidyl-proline dioxygenase activity | 2.68e-04 | 12 | 41 | 2 | GO:0031543 | |
| GeneOntologyMolecularFunction | L-ascorbic acid binding | 7.63e-04 | 20 | 41 | 2 | GO:0031418 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 7.84e-04 | 1244 | 41 | 9 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 9.14e-04 | 1271 | 41 | 9 | GO:0000987 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 9.24e-04 | 560 | 41 | 6 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 9.77e-04 | 566 | 41 | 6 | GO:0001216 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 1.91e-03 | 1412 | 41 | 9 | GO:0000981 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2.40e-03 | 1459 | 41 | 9 | GO:0000977 | |
| GeneOntologyBiologicalProcess | embryonic skeletal system morphogenesis | 1.84e-09 | 109 | 41 | 7 | GO:0048704 | |
| GeneOntologyBiologicalProcess | embryonic skeletal system development | 1.56e-08 | 148 | 41 | 7 | GO:0048706 | |
| GeneOntologyBiologicalProcess | anterior/posterior pattern specification | 2.57e-08 | 247 | 41 | 8 | GO:0009952 | |
| GeneOntologyBiologicalProcess | skeletal system morphogenesis | 6.22e-08 | 277 | 41 | 8 | GO:0048705 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 3.80e-07 | 351 | 41 | 8 | GO:0048562 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 9.71e-07 | 713 | 41 | 10 | GO:0048598 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 1.23e-06 | 561 | 41 | 9 | GO:0048568 | |
| GeneOntologyBiologicalProcess | skeletal system development | 2.62e-06 | 615 | 41 | 9 | GO:0001501 | |
| GeneOntologyBiologicalProcess | regionalization | 3.83e-06 | 478 | 41 | 8 | GO:0003002 | |
| GeneOntologyBiologicalProcess | pattern specification process | 7.72e-06 | 526 | 41 | 8 | GO:0007389 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 8.24e-06 | 906 | 41 | 10 | GO:0043009 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 1.03e-05 | 929 | 41 | 10 | GO:0009792 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | SREBF1 HOXA4 MAML1 HOXA5 IL10 HOXA7 HOXB5 TSC2 HOXC4 NEUROG1 HOXD4 | 6.02e-05 | 1390 | 41 | 11 | GO:0045944 |
| GeneOntologyBiologicalProcess | embryo development | HOXA4 HOXA5 IL10 HOXA7 HOXB5 HOXB6 TSC2 HOXC4 NEUROG1 HOXD4 TIE1 | 8.13e-05 | 1437 | 41 | 11 | GO:0009790 |
| MousePheno | cervical vertebral transformation | 4.41e-08 | 41 | 34 | 5 | MP:0004615 | |
| MousePheno | vertebral transformation | 2.33e-07 | 110 | 34 | 6 | MP:0003036 | |
| MousePheno | increased rib number | 3.37e-06 | 43 | 34 | 4 | MP:0000480 | |
| MousePheno | abnormal cervical vertebrae morphology | 9.78e-06 | 120 | 34 | 5 | MP:0003048 | |
| MousePheno | abnormal presacral vertebrae morphology | 1.50e-05 | 225 | 34 | 6 | MP:0000459 | |
| MousePheno | increased sternebra number | 1.20e-04 | 7 | 34 | 2 | MP:0012284 | |
| MousePheno | thick pulmonary interalveolar septum | 1.63e-04 | 44 | 34 | 3 | MP:0001179 | |
| MousePheno | thoracic vertebral transformation | 2.53e-04 | 51 | 34 | 3 | MP:0004618 | |
| MousePheno | abnormal sternebra morphology | 2.68e-04 | 52 | 34 | 3 | MP:0004322 | |
| MousePheno | abnormal pulmonary interalveolar septum morphology | 3.16e-04 | 55 | 34 | 3 | MP:0010900 | |
| MousePheno | abnormal rib morphology | 3.63e-04 | 257 | 34 | 5 | MP:0000150 | |
| MousePheno | abnormal sternebra number | 4.40e-04 | 13 | 34 | 2 | MP:0012282 | |
| Domain | Homeobox_antennapedia | 1.35e-16 | 12 | 42 | 7 | IPR017995 | |
| Domain | Homeobox_Antennapedia_CS | 1.95e-14 | 21 | 42 | 7 | IPR001827 | |
| Domain | ANTENNAPEDIA | 5.78e-14 | 24 | 42 | 7 | PS00032 | |
| Domain | Homeobox_metazoa | 1.12e-09 | 90 | 42 | 7 | IPR020479 | |
| Domain | Homeobox_CS | 1.74e-07 | 186 | 42 | 7 | IPR017970 | |
| Domain | Homeobox | 8.23e-07 | 234 | 42 | 7 | PF00046 | |
| Domain | HOMEOBOX_1 | 8.71e-07 | 236 | 42 | 7 | PS00027 | |
| Domain | HOX | 8.96e-07 | 237 | 42 | 7 | SM00389 | |
| Domain | Homeobox_dom | 9.48e-07 | 239 | 42 | 7 | IPR001356 | |
| Domain | HOMEOBOX_2 | 9.48e-07 | 239 | 42 | 7 | PS50071 | |
| Domain | - | 2.92e-06 | 283 | 42 | 7 | 1.10.10.60 | |
| Domain | Homeodomain-like | 8.32e-06 | 332 | 42 | 7 | IPR009057 | |
| Domain | 2OG-FeII_Oxy_3 | 2.68e-04 | 11 | 42 | 2 | PF13640 | |
| Domain | Pro_4_hyd_alph | 5.81e-04 | 16 | 42 | 2 | IPR006620 | |
| Domain | P4Hc | 5.81e-04 | 16 | 42 | 2 | SM00702 | |
| Domain | 2OG-FeII_Oxy | 8.24e-04 | 19 | 42 | 2 | PF03171 | |
| Domain | FE2OG_OXY | 1.01e-03 | 21 | 42 | 2 | PS51471 | |
| Domain | Oxoglu/Fe-dep_dioxygenase | 1.21e-03 | 23 | 42 | 2 | IPR005123 | |
| Domain | ER_TARGET | 5.01e-03 | 47 | 42 | 2 | PS00014 | |
| Domain | TPR-like_helical_dom | 1.54e-02 | 233 | 42 | 3 | IPR011990 | |
| Pubmed | The Polycomb-group homolog Bmi-1 is a regulator of murine Hox gene expression. | 3.77e-18 | 13 | 42 | 7 | 8887324 | |
| Pubmed | The mouse PcG gene eed is required for Hox gene repression and extraembryonic development. | 1.69e-16 | 20 | 42 | 7 | 12370779 | |
| Pubmed | 3.72e-16 | 22 | 42 | 7 | 2576652 | ||
| Pubmed | 7.54e-16 | 24 | 42 | 7 | 9367423 | ||
| Pubmed | 2.71e-14 | 38 | 42 | 7 | 15042701 | ||
| Pubmed | 2.71e-14 | 38 | 42 | 7 | 11857506 | ||
| Pubmed | 3.31e-14 | 39 | 42 | 7 | 33257809 | ||
| Pubmed | Quantification of Hox and surfactant protein-B transcription during murine lung development. | 4.00e-14 | 40 | 42 | 7 | 19204410 | |
| Pubmed | 4.82e-14 | 41 | 42 | 7 | 32479258 | ||
| Pubmed | 6.90e-14 | 43 | 42 | 7 | 22701719 | ||
| Pubmed | 8.20e-14 | 44 | 42 | 7 | 1973146 | ||
| Pubmed | Hox genes regulate the onset of Tbx5 expression in the forelimb. | 1.12e-13 | 8 | 42 | 5 | 22872086 | |
| Pubmed | Crypto-rhombomeres of the mouse medulla oblongata, defined by molecular and morphological features. | 1.14e-13 | 21 | 42 | 6 | 25381007 | |
| Pubmed | 1.34e-13 | 47 | 42 | 7 | 1358459 | ||
| Pubmed | New insights into the role of Jmjd3 and Utx in axial skeletal formation in mice. | 2.13e-13 | 50 | 42 | 7 | 28188179 | |
| Pubmed | Coordinated expression of 3' hox genes during murine embryonal gut development: an enteric Hox code. | 2.52e-13 | 9 | 42 | 5 | 10579975 | |
| Pubmed | Region-specific gastrointestinal Hox code during murine embryonal gut development. | 2.52e-13 | 9 | 42 | 5 | 11869294 | |
| Pubmed | 4.83e-13 | 26 | 42 | 6 | 8646877 | ||
| Pubmed | 1.58e-12 | 12 | 42 | 5 | 9415485 | ||
| Pubmed | Expression of class I homeobox genes in fetal and adult murine skin. | 1.58e-12 | 12 | 42 | 5 | 8105001 | |
| Pubmed | Sf3b4 regulates chromatin remodeler splicing and Hox expression. | 1.89e-12 | 32 | 42 | 6 | 37167859 | |
| Pubmed | 2.56e-12 | 13 | 42 | 5 | 8625838 | ||
| Pubmed | 3.99e-12 | 14 | 42 | 5 | 8099712 | ||
| Pubmed | Corepressor SMRT is required to maintain Hox transcriptional memory during somitogenesis. | 4.03e-11 | 21 | 42 | 5 | 30254164 | |
| Pubmed | 6.41e-11 | 7 | 42 | 4 | 7680626 | ||
| Pubmed | 6.65e-11 | 23 | 42 | 5 | 28041967 | ||
| Pubmed | 1.06e-10 | 118 | 42 | 7 | 16971476 | ||
| Pubmed | 2.33e-10 | 29 | 42 | 5 | 23843306 | ||
| Pubmed | 9.78e-10 | 38 | 42 | 5 | 1683707 | ||
| Pubmed | 1.30e-09 | 13 | 42 | 4 | 24525295 | ||
| Pubmed | 1.82e-09 | 14 | 42 | 4 | 19922872 | ||
| Pubmed | 1.82e-09 | 14 | 42 | 4 | 1348361 | ||
| Pubmed | 5.55e-09 | 18 | 42 | 4 | 23359544 | ||
| Pubmed | Growth disturbance in fetal liver hematopoiesis of Mll-mutant mice. | 5.55e-09 | 18 | 42 | 4 | 9639506 | |
| Pubmed | Expression of a homeo domain protein in noncontact-inhibited cultured cells and postmitotic neurons. | 6.54e-09 | 4 | 42 | 3 | 2890554 | |
| Pubmed | 6.54e-09 | 4 | 42 | 3 | 7909996 | ||
| Pubmed | 6.54e-09 | 4 | 42 | 3 | 7628700 | ||
| Pubmed | Independent regulation of vertebral number and vertebral identity by microRNA-196 paralogs. | 1.32e-08 | 22 | 42 | 4 | 26283362 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 1.48e-08 | 544 | 42 | 9 | 28473536 | |
| Pubmed | 3.27e-08 | 6 | 42 | 3 | 7918106 | ||
| Pubmed | 4.27e-08 | 29 | 42 | 4 | 2574852 | ||
| Pubmed | Sequence and embryonic expression of the murine Hox-3.5 gene. | 5.71e-08 | 7 | 42 | 3 | 1363091 | |
| Pubmed | Targeted disruption of hoxc-4 causes esophageal defects and vertebral transformations. | 5.71e-08 | 7 | 42 | 3 | 8660891 | |
| Pubmed | 5.71e-08 | 7 | 42 | 3 | 16618927 | ||
| Pubmed | Critical role of the p400/mDomino chromatin-remodeling ATPase in embryonic hematopoiesis. | 6.44e-08 | 32 | 42 | 4 | 17535249 | |
| Pubmed | 9.13e-08 | 8 | 42 | 3 | 1976088 | ||
| Pubmed | 9.13e-08 | 8 | 42 | 3 | 2890503 | ||
| Pubmed | Expression of HOX homeogenes in human neuroblastoma cell culture lines. | 9.13e-08 | 8 | 42 | 3 | 1981366 | |
| Pubmed | Altered cellular proliferation and mesoderm patterning in Polycomb-M33-deficient mice. | 1.37e-07 | 9 | 42 | 3 | 9043087 | |
| Pubmed | 2.68e-07 | 11 | 42 | 3 | 16024804 | ||
| Pubmed | Genomic maps and comparative analysis of histone modifications in human and mouse. | 3.58e-07 | 12 | 42 | 3 | 15680324 | |
| Pubmed | 3.58e-07 | 12 | 42 | 3 | 25099890 | ||
| Pubmed | Orientation of the Hoxa complex and placement of the Hd locus distal to Hoxa2 on mouse chromosome 6. | 3.58e-07 | 12 | 42 | 3 | 8833244 | |
| Pubmed | 5.62e-07 | 251 | 42 | 6 | 29031500 | ||
| Pubmed | A distinct Hox code for the branchial region of the vertebrate head. | 7.38e-07 | 15 | 42 | 3 | 1682814 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 8.36e-07 | 877 | 42 | 9 | 20211142 | |
| Pubmed | 9.07e-07 | 16 | 42 | 3 | 22219351 | ||
| Pubmed | 1.10e-06 | 17 | 42 | 3 | 17626057 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 1.11e-06 | 908 | 42 | 9 | 19274049 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 2563568 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 9603431 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 18487197 | ||
| Pubmed | Expression Landscape and Functional Roles of HOXA4 and HOXA5 in Lung Adenocarcinoma. | 1.42e-06 | 2 | 42 | 2 | 35370463 | |
| Pubmed | LAG-3 Inhibitory Receptor Expression Identifies Immunosuppressive Natural Regulatory Plasma Cells. | 1.42e-06 | 2 | 42 | 2 | 30005826 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 7654365 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 32721103 | ||
| Pubmed | Methylation of HoxA5 and HoxB5 and its relevance to expression during mouse development. | 1.42e-06 | 2 | 42 | 2 | 12527197 | |
| Pubmed | Structure and expression of Hox-2.2, a murine homeobox-containing gene. | 1.42e-06 | 2 | 42 | 2 | 2899893 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 6091895 | ||
| Pubmed | 1.57e-06 | 19 | 42 | 3 | 15741318 | ||
| Pubmed | Ablation of Ezh2 in neural crest cells leads to aberrant enteric nervous system development in mice. | 1.84e-06 | 20 | 42 | 3 | 30169530 | |
| Pubmed | Sustained Hox5 gene activity is required for respiratory motor neuron development. | 1.84e-06 | 20 | 42 | 3 | 23103965 | |
| Pubmed | MicroRNA 196B Regulates HOXA5, HOXB6 and GLTP Expression Levels in Colorectal Cancer Cells. | 4.27e-06 | 3 | 42 | 2 | 29532406 | |
| Pubmed | Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia. | 4.27e-06 | 3 | 42 | 2 | 25585874 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 18553509 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 27579997 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 25565629 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 8688592 | ||
| Pubmed | Genetic interaction between hoxb-5 and hoxb-6 is revealed by nonallelic noncomplementation. | 4.27e-06 | 3 | 42 | 2 | 7828847 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 16339216 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 21049546 | ||
| Pubmed | HOX homeobox genes exhibit spatial and temporal changes in expression during human skin development. | 4.27e-06 | 3 | 42 | 2 | 9457903 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 22603795 | ||
| Pubmed | Prolyl 3-hydroxylase 1, enzyme characterization and identification of a novel family of enzymes. | 4.27e-06 | 3 | 42 | 2 | 15044469 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 21245029 | ||
| Pubmed | HOX genes in human lung: altered expression in primary pulmonary hypertension and emphysema. | 4.27e-06 | 3 | 42 | 2 | 11238043 | |
| Pubmed | Clustered homeo boxes are differentially expressed during murine development. | 4.27e-06 | 3 | 42 | 2 | 2416462 | |
| Pubmed | Expression of prolyl 3-hydroxylase genes in embryonic and adult mouse tissues. | 4.27e-06 | 3 | 42 | 2 | 19652424 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 21546695 | ||
| Pubmed | Ribosome-mediated specificity in Hox mRNA translation and vertebrate tissue patterning. | 5.63e-06 | 96 | 42 | 4 | 21529712 | |
| Pubmed | 5.85e-06 | 29 | 42 | 3 | 33298461 | ||
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 2575552 | ||
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 3000607 | ||
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 7912569 | ||
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 2576400 | ||
| Pubmed | A new homeo-box is present in overlapping cosmid clones which define the mouse Hox-1 locus. | 8.53e-06 | 4 | 42 | 2 | 3019676 | |
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 10633854 | ||
| Pubmed | Retinoids regulate the anterior expression boundaries of 5' Hoxb genes in posterior hindbrain. | 8.53e-06 | 4 | 42 | 2 | 12514132 | |
| Pubmed | Fat accumulation in differentiated brown adipocytes is linked with expression of Hox genes. | 8.53e-06 | 4 | 42 | 2 | 26820751 | |
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 9106661 | ||
| Interaction | ANKRD17 interactions | 2.77e-07 | 226 | 40 | 7 | int:ANKRD17 | |
| Interaction | PBX1 interactions | 6.94e-07 | 85 | 40 | 5 | int:PBX1 | |
| Interaction | ANKHD1-EIF4EBP3 interactions | 2.28e-06 | 108 | 40 | 5 | int:ANKHD1-EIF4EBP3 | |
| Interaction | HOXB7 interactions | 1.82e-05 | 26 | 40 | 3 | int:HOXB7 | |
| Interaction | ANKHD1 interactions | 6.55e-05 | 216 | 40 | 5 | int:ANKHD1 | |
| Interaction | KRBA1 interactions | 7.33e-05 | 41 | 40 | 3 | int:KRBA1 | |
| Interaction | MEIS1 interactions | 1.50e-04 | 52 | 40 | 3 | int:MEIS1 | |
| Cytoband | 7p15.2 | 8.56e-06 | 43 | 42 | 3 | 7p15.2 | |
| Cytoband | 17q21.3 | 9.73e-05 | 16 | 42 | 2 | 17q21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p15 | 1.11e-04 | 101 | 42 | 3 | chr7p15 | |
| Cytoband | 1p34.1 | 1.26e-03 | 57 | 42 | 2 | 1p34.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p34 | 2.48e-03 | 294 | 42 | 3 | chr1p34 | |
| GeneFamily | HOXL subclass homeoboxes | 6.75e-13 | 52 | 26 | 7 | 518 | |
| GeneFamily | Basic helix-loop-helix proteins | 1.08e-02 | 110 | 26 | 2 | 420 | |
| Coexpression | ALCALAY_AML_BY_NPM1_LOCALIZATION_UP | 9.34e-08 | 140 | 42 | 6 | M9377 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 | 2.37e-07 | 272 | 42 | 7 | M1938 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 | 3.03e-07 | 282 | 42 | 7 | MM822 | |
| Coexpression | VALK_AML_WITH_FLT3_ITD | 5.52e-07 | 41 | 42 | 4 | M10010 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_7P15_AMPLICON | 6.26e-07 | 11 | 42 | 3 | M18241 | |
| Coexpression | VERHAAK_AML_WITH_NPM1_MUTATED_UP | 1.20e-05 | 187 | 42 | 5 | M4861 | |
| Coexpression | IM_SREBF1A_TARGETS | 2.50e-05 | 5 | 42 | 2 | M2433 | |
| Coexpression | IM_SREBF1A_TARGETS | 2.50e-05 | 5 | 42 | 2 | MM941 | |
| Coexpression | MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP | 6.37e-05 | 265 | 42 | 5 | M19170 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 1.08e-04 | 479 | 42 | 6 | M2573 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 1.13e-04 | 483 | 42 | 6 | MM1082 | |
| Coexpression | ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_6HR_DN | 1.42e-04 | 63 | 42 | 3 | M41065 | |
| Coexpression | MULLIGHAN_NPM1_SIGNATURE_3_UP | 1.91e-04 | 335 | 42 | 5 | M10277 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_1 | 1.93e-04 | 13 | 42 | 2 | M1383 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_DN | 2.61e-04 | 194 | 42 | 4 | M8864 | |
| Coexpression | ROSS_LEUKEMIA_WITH_MLL_FUSIONS | 2.78e-04 | 79 | 42 | 3 | M12695 | |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_DN | 2.93e-04 | 200 | 42 | 4 | M9441 | |
| Coexpression | GSE26912_TUMORICIDAL_VS_CTRL_MACROPHAGE_DN | 2.93e-04 | 200 | 42 | 4 | M8206 | |
| Coexpression | GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP | 2.93e-04 | 200 | 42 | 4 | M2933 | |
| Coexpression | GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP | 2.93e-04 | 200 | 42 | 4 | M4313 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_1 | 2.97e-04 | 16 | 42 | 2 | MM1133 | |
| CoexpressionAtlas | gudmap_RNAseq_p2_CD2APMEISWT_2500_K2 | 3.47e-08 | 99 | 41 | 6 | gudmap_RNAseq_p2_CD2APMEISWT_2500_K2 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K0 | 1.84e-07 | 67 | 41 | 5 | gudmap_RNAseq_e15.5_Mesangium_2500_K0 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_100 | 1.37e-06 | 100 | 41 | 5 | PCBC_ratio_EB_vs_SC_100 | |
| CoexpressionAtlas | gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K3 | 1.41e-06 | 185 | 41 | 6 | gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K3 | |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_tips_2500_K2 | 1.70e-06 | 304 | 41 | 7 | gudmap_RNAseq_e11.5_Ureteric_tips_2500_K2 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | HOXA4 HOXA5 HOXA7 GIPR HOXB5 HOXB6 HOXC4 NEUROG1 HOXD4 LRRC10B | 1.44e-05 | 994 | 41 | 10 | PCBC_ratio_EB_vs_SC_1000 |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K2 | 1.94e-05 | 441 | 41 | 7 | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K2 | |
| CoexpressionAtlas | Embryoid Body Cells-method_mRNA_vs_Embryoid Body Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | 1.96e-05 | 293 | 41 | 6 | PCBC_ratio_EB_from-mRNA_vs_EB_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Embryoid Body Cells-reprogram_OSKM-L_vs_Embryoid Body Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 1.96e-05 | 293 | 41 | 6 | PCBC_ratio_EB_from-OSKM-L_vs_EB_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 3.47e-05 | 194 | 41 | 5 | gudmap_kidney_P0_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_500 | 3.64e-05 | 196 | 41 | 5 | gudmap_kidney_P1_CapMes_Crym_k4_500 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 3.79e-05 | 98 | 41 | 4 | gudmap_kidney_P2_CapMes_Crym_k3_200 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 4.21e-05 | 202 | 41 | 5 | gudmap_kidney_P2_CapMes_Crym_k3_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500 | 4.22e-05 | 498 | 41 | 7 | PCBC_ratio_EB_vs_SC_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.96e-05 | 110 | 41 | 4 | gudmap_developingGonad_e11.5_ovary + mesonephros_k3_1000 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_200 | 8.36e-05 | 120 | 41 | 4 | gudmap_kidney_P1_CapMes_Crym_200 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_200 | 9.49e-05 | 124 | 41 | 4 | gudmap_kidney_P0_CapMes_Crym_200 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Endothelial_2500_K0 | 1.01e-04 | 126 | 41 | 4 | gudmap_RNAseq_e15.5_Endothelial_2500_K0 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.12e-04 | 401 | 41 | 6 | gudmap_kidney_P1_CapMes_Crym_k1_1000 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_200 | 1.48e-04 | 139 | 41 | 4 | gudmap_kidney_P2_CapMes_Crym_200 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_500 | 1.83e-04 | 276 | 41 | 5 | gudmap_kidney_P1_CapMes_Crym_500 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_500 | 2.34e-04 | 291 | 41 | 5 | gudmap_kidney_P2_CapMes_Crym_500 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_500 | 2.45e-04 | 294 | 41 | 5 | gudmap_kidney_P0_CapMes_Crym_500 | |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K4 | 2.48e-04 | 662 | 41 | 7 | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K4 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 2.91e-04 | 166 | 41 | 4 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | kidney_e10.5_UretericTrunk_HoxB7_k-means-cluster#1_top-relative-expression-ranked_200 | 4.29e-04 | 16 | 41 | 2 | gudmap_kidney_e10.5_UretericTrunk_HoxB7_k1_200 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#2 | 4.60e-04 | 78 | 41 | 3 | ratio_EB_vs_SC_500_K2 | |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_k-means-cluster#1_top-relative-expression-ranked_200 | 4.86e-04 | 17 | 41 | 2 | gudmap_kidney_e10.5_UretericTip_HoxB7_k1_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.76e-04 | 89 | 41 | 3 | gudmap_developingGonad_e11.5_testes_k1_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.99e-04 | 90 | 41 | 3 | gudmap_developingGonad_e11.5_testes and mesonephros_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_1000 | 9.21e-04 | 99 | 41 | 3 | gudmap_developingGonad_e14.5_ epididymis_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | 1.05e-03 | 843 | 41 | 7 | gudmap_developingGonad_e11.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000 | 1.05e-03 | 844 | 41 | 7 | gudmap_developingGonad_e11.5_testes and mesonephros_1000 | |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_500_k-means-cluster#1 | 1.09e-03 | 105 | 41 | 3 | JC_iEC_500_K1 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_1000 | 1.27e-03 | 633 | 41 | 6 | gudmap_kidney_P1_CapMes_Crym_1000 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_1000 | 1.33e-03 | 639 | 41 | 6 | gudmap_kidney_P0_CapMes_Crym_1000 | |
| CoexpressionAtlas | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K1 | 1.43e-03 | 29 | 41 | 2 | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K1 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-07 | 167 | 42 | 5 | a66552667aa6e8992c159df27a57c2e8ae14a9ce | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-07 | 167 | 42 | 5 | 1248f809afbcccb42ce9e29cfe6fa1f6f6b65005 | |
| ToppCell | facs-Aorta|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-07 | 176 | 42 | 5 | 0b3491451be02c18a16cdb875645be47eb867a7f | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like|lymph-node_spleen / Manually curated celltypes from each tissue | 8.15e-07 | 184 | 42 | 5 | d97471a4fe17cba6880ccf1a04cc00c741558124 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-05 | 150 | 42 | 4 | 580ed7733857402345f43ca2623f72cdd1edf22c | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Mast_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.40e-05 | 156 | 42 | 4 | 17c38d3b03fc38cb125cf0d165b2fd694cd88edd | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.59e-05 | 161 | 42 | 4 | aee74a2e7a8acd2950341963f1c04b59c7862183 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 1.79e-05 | 166 | 42 | 4 | 773673a5d0430640439845b264740bfbbdad0cb2 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like|GI_small-bowel / Manually curated celltypes from each tissue | 1.84e-05 | 167 | 42 | 4 | 3ae46c6363da76c8e1f5579e6027bf88ed637a44 | |
| ToppCell | Healthy_donor-HSPC|World / disease group, cell group and cell class (v2) | 1.84e-05 | 167 | 42 | 4 | 70630ebdfee8171d625811844f8a7c94736d101e | |
| ToppCell | facs-Large_Intestine-Proximal|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-05 | 168 | 42 | 4 | 23e0e1592d7400012d289adb10c7598285bae2e9 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-05 | 168 | 42 | 4 | e8878ec68b21c8d5694d7209b816d2f869673164 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-05 | 168 | 42 | 4 | a007758c219d3d5db2b5529f29af63be0d408304 | |
| ToppCell | COVID-19_Convalescent-Hematopoietic_SC|COVID-19_Convalescent / Disease group, lineage and cell class | 1.97e-05 | 170 | 42 | 4 | 8a73d5334eed1cd9fdcc3ebeae0bdf9f945c228a | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.01e-05 | 171 | 42 | 4 | 172db31a37b72fb87fe5f0f79da51866b90dd1ad | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.01e-05 | 171 | 42 | 4 | 2031797d579ce373921affad70da6e50eec13664 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.01e-05 | 171 | 42 | 4 | a4e13b304ef414722ffdc06560deeab41785e956 | |
| ToppCell | Healthy_donor-HSPC|Healthy_donor / disease group, cell group and cell class (v2) | 2.06e-05 | 172 | 42 | 4 | bc7549faadfc92c683c0e26bea380458706774b5 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.06e-05 | 172 | 42 | 4 | 8fd3db757d54949bd583d5f0eadf63a32342cb9d | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.06e-05 | 172 | 42 | 4 | 382cb5fea099110eb026a8bba6cf4c28763ea52f | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.06e-05 | 172 | 42 | 4 | da78f7a71b7f05c5c484c9ed19ba37c55d35e870 | |
| ToppCell | 10x5'-blood-Mast-Mast_cells|blood / Manually curated celltypes from each tissue | 2.16e-05 | 174 | 42 | 4 | a5838821bba2be790d32331ff529d466e9974268 | |
| ToppCell | 10x5'-blood-Mast|blood / Manually curated celltypes from each tissue | 2.16e-05 | 174 | 42 | 4 | 3a8a253213b207e3ff56f94a74996b8d9ad47aa1 | |
| ToppCell | severe_COVID-19-HSPC|severe_COVID-19 / disease group, cell group and cell class (v2) | 2.16e-05 | 174 | 42 | 4 | 6d35bacf073537b272ff821e604c899fb9ce6a7c | |
| ToppCell | moderate-Myeloid-Mast_cell|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.21e-05 | 175 | 42 | 4 | bbd2971bc6d69e507f90a637834d0936c205c590 | |
| ToppCell | 3'_v3-blood-Mast-Mast_cells|blood / Manually curated celltypes from each tissue | 2.26e-05 | 176 | 42 | 4 | b9da3deaf62622d47eb30b6be7548253eee95597 | |
| ToppCell | severe_COVID-19-HSPC|World / disease group, cell group and cell class (v2) | 2.31e-05 | 177 | 42 | 4 | 289f6aed6f054b04b01659434d8c8b467d1bf5dd | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-CD45____plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 177 | 42 | 4 | f0487e3b439f7803e465cad44916e2e271f33d6d | |
| ToppCell | COVID-19_Mild-Hematopoietic_SC-HSPC|COVID-19_Mild / Disease group, lineage and cell class | 2.41e-05 | 179 | 42 | 4 | 19fcf48f5e02e4cb2b328efb4502f337e1282f72 | |
| ToppCell | Endothelial-A-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 2.41e-05 | 179 | 42 | 4 | 138fd6ba6bdbd0ad01c574168addf720b67a0fea | |
| ToppCell | COVID-19_Mild-Hematopoietic_SC|COVID-19_Mild / Disease group, lineage and cell class | 2.41e-05 | 179 | 42 | 4 | 50a073166e34bcfa52a62c4dafb3aef724e0fa8e | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.46e-05 | 180 | 42 | 4 | 289f8c4b53ffd164fee1f459a9315c0deb5f76d0 | |
| ToppCell | 3'_v3-bone_marrow-Mast|bone_marrow / Manually curated celltypes from each tissue | 2.46e-05 | 180 | 42 | 4 | b37ee81b792213d6595b4ec65d04bc35d83321c7 | |
| ToppCell | 3'_v3-bone_marrow-Mast-Mast_cells|bone_marrow / Manually curated celltypes from each tissue | 2.52e-05 | 181 | 42 | 4 | 30ec4635474ee0f0ea1415ec0ba7f008d97e8c1a | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 181 | 42 | 4 | fb64da1dde37fe6ba7de2586cd58848ac1974f24 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.57e-05 | 182 | 42 | 4 | 6497eeafb2b137e70261ec0314782831892a940d | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 182 | 42 | 4 | 33afbb7c4352b03266501b1f4f0e751c12c7350d | |
| ToppCell | Control-Hematopoietic_SC-HSPC|Control / Disease group, lineage and cell class | 2.57e-05 | 182 | 42 | 4 | 14e347c0e6444410f1948851407bb18c706569f4 | |
| ToppCell | Control-Hematopoietic_SC|Control / Disease group, lineage and cell class | 2.57e-05 | 182 | 42 | 4 | 43243c6bae2ac7fa3fd1f193a17f61ee4d938ea9 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.57e-05 | 182 | 42 | 4 | d0ebf2f0d5370458ab81485a0017c311077133d5 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.57e-05 | 182 | 42 | 4 | 918286422b3eab32d962b49aa07b1b9512e51d9d | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.57e-05 | 182 | 42 | 4 | bd1626261803324084fafca2f6665b50854e7fae | |
| ToppCell | Immune_cells-Dendritic_cells|Immune_cells / Lineage and Cell class | 2.57e-05 | 182 | 42 | 4 | 99c7d4f1e7cd745643ba64b59190113bcd4e348e | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.57e-05 | 182 | 42 | 4 | 2a6d1246bfb5899a0861c7f2f8fb9b43b0df8acc | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.57e-05 | 182 | 42 | 4 | 0d9b8c900da8cbae9cde72aecd4026b1ac2bbd67 | |
| ToppCell | 21-Trachea-Mesenchymal-Airway_Smooth_Muscle|Trachea / Age, Tissue, Lineage and Cell class | 2.68e-05 | 184 | 42 | 4 | 86a96cd88e50eacad1f0badfbbf6dc626f41725e | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 185 | 42 | 4 | 65dcb0a7ee64990a34a87c167b44497107f035ee | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.74e-05 | 185 | 42 | 4 | 9d53e0a92e4f99370be2e4be1dd737630796b1ca | |
| ToppCell | Endothelial-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.74e-05 | 185 | 42 | 4 | 133c9dc64d564dae4aeeeca22f386aa3f13fa980 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.80e-05 | 186 | 42 | 4 | 722da08cd978249a19855fd3ec8ddda780c99d83 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.86e-05 | 187 | 42 | 4 | fa0452f3382c22c0391b241d06504fda3c6a19f0 | |
| ToppCell | TCGA-Prostate-Primary_Tumor|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.86e-05 | 187 | 42 | 4 | 3e6a95c912dad5d61e10497ffaafd2b9027cd13a | |
| ToppCell | normal-na-Hematopoietic-progenitor_cell|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.92e-05 | 188 | 42 | 4 | 013162466a3334b6967c0cb670c8577d809b1396 | |
| ToppCell | normal-na-Hematopoietic-progenitor_cell-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.92e-05 | 188 | 42 | 4 | be25371e6459504b5f0c9ece3a0fe8f80c7824ca | |
| ToppCell | Healthy-HSPC|Healthy / disease group, cell group and cell class | 2.98e-05 | 189 | 42 | 4 | 214b225effc40ca1b83dd8052f2a7b80b65d4938 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-05 | 190 | 42 | 4 | 8cb950effc449ae59a915132ecc079be54d1acfe | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-05 | 190 | 42 | 4 | 17a73a658fb30a4322b31e38db7b240023738f29 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-05 | 190 | 42 | 4 | 5dfbd064ab1f8a0b18b5975c47f8e79697f3db15 | |
| ToppCell | Megakaryocytic-erythropoietic-MEP|World / Lineage, cell class and subclass | 3.10e-05 | 191 | 42 | 4 | 91bbc9d3a9ecc49262060faeb0047764828c1960 | |
| ToppCell | Megakaryocytic-erythropoietic-MEP-MEP|World / Lineage, cell class and subclass | 3.10e-05 | 191 | 42 | 4 | b71dc4e27a22955926547493fc959afc20208566 | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.37e-05 | 195 | 42 | 4 | 97b2ff072cc830a4a2cb217f5a215ca6cad505ec | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.37e-05 | 195 | 42 | 4 | 22a481927147ec4ae9d59e6af7c87df0e9cb51e4 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Fibroblasts|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.37e-05 | 195 | 42 | 4 | 5870b2956d50d6550a3174a220a6cc70c5538d70 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.37e-05 | 195 | 42 | 4 | 12ba6d95e42d06b1991b011043c0e3370a7b4131 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.43e-05 | 196 | 42 | 4 | d37d821229dce716a05c2a5865415e10f79032de | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.43e-05 | 196 | 42 | 4 | 62b2de1d38a99ab23211bf51595845f8a1fdb7d2 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Others-HSPC|COVID-19_Convalescent / Disease, condition lineage and cell class | 3.50e-05 | 197 | 42 | 4 | c1033a1a8b8b5c8569130aa9405a6e8e65ef7bd0 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.57e-05 | 198 | 42 | 4 | 2ee8ac82ef1b8ebabc8dd824211bbb471f2af8ac | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Early_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.64e-05 | 199 | 42 | 4 | d67f5ae05daf942fb79f5b962021f37f4e275f4d | |
| ToppCell | Caecum-ILC|Caecum / Region, Cell class and subclass | 3.72e-05 | 200 | 42 | 4 | a9a1f03b4f415da860fb52eaedb07f0743692c98 | |
| ToppCell | Caecum-ILC-ILC|Caecum / Region, Cell class and subclass | 3.72e-05 | 200 | 42 | 4 | 3ac18c3ef335cb83d6a826f6c7519a5e7804929d | |
| ToppCell | Caecum-(3)_ILC|Caecum / shred on region, Cell_type, and subtype | 3.72e-05 | 200 | 42 | 4 | 6857863b3200162c250123688af2cba681afcb35 | |
| ToppCell | Caecum-(3)_ILC-(30)_ILC|Caecum / shred on region, Cell_type, and subtype | 3.72e-05 | 200 | 42 | 4 | ccd323997613b65f0189c0c66d76fbf273e18c03 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-04 | 117 | 42 | 3 | c6fc72608d56a389bcd87b5dc98a11e39b79bcb2 | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.97e-04 | 120 | 42 | 3 | a320799ab5f2ce872e038b15841a23174c5436e8 | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Blood_Derived_Cancer_-_Peripheral_Blood-Leukemia-Acute_Myeloid_Leukemia-6|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 2.22e-04 | 125 | 42 | 3 | dd59d6ca4d36f9453eb1b1f260fab36c5d641cb2 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Proliferative_AT1_Progenitor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.66e-04 | 133 | 42 | 3 | b0d3ac5abd9ebd490db46a3ef2e4ae88c4bf4e34 | |
| ToppCell | TCGA-Prostate-Solid_Tissue_Normal-Prostate_normal_tissue-Prostate_normal_tissue-3|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.66e-04 | 133 | 42 | 3 | 3e0e37dfb07a2de72e2b49f32ff201c3ec56f247 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Smooth_Muscle-like_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.10e-04 | 140 | 42 | 3 | 5623a0a68403fc00166b7d13d13e184a718d9bdd | |
| ToppCell | IIH-CD8-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 3.50e-04 | 146 | 42 | 3 | 7fa6e35def3f7cffbee1e1c2f10b523bab678e14 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.57e-04 | 147 | 42 | 3 | 27e97a7b1dc296f52990b5810a52ab0a7ef2b9e6 | |
| ToppCell | 10x5'-blood-Myeloid_Mac-Intermediate_macrophages|blood / Manually curated celltypes from each tissue | 3.64e-04 | 148 | 42 | 3 | b801f38d249a02c4ceceb242cabbbc88418e5fd1 | |
| ToppCell | 10x5'-blood-Myeloid_Mac|blood / Manually curated celltypes from each tissue | 3.64e-04 | 148 | 42 | 3 | 1ae2d7475e030e2de49940f3287b02953dbf3c65 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-MPP_myeloid|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.02e-04 | 153 | 42 | 3 | 9ff31b07f5bdbd4d0211eae2fb38d3f2830bb4d6 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-04 | 154 | 42 | 3 | 5ed64bbf603290e6dc34f81d145982690b89dd0d | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-04 | 157 | 42 | 3 | fc127e7720649e746f3d3f5c2e9e63784767106a | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-04 | 157 | 42 | 3 | 66a191cef4aa00811bb04462310d012610006f85 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma|TCGA-Bladder / Sample_Type by Project: Shred V9 | 4.41e-04 | 158 | 42 | 3 | dc559503bab3ec1b9ea54ef2e896d1be33e5344c | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.49e-04 | 159 | 42 | 3 | 2fb1d2ff52920aeb48d048cf29f0cd45f944a73d | |
| ToppCell | NS-critical-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.58e-04 | 160 | 42 | 3 | c61869d9dbba250270e59366e15af204e5b4395d | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-04 | 160 | 42 | 3 | 984990be02642a562f0c60ea99c01f005e7c02c2 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.66e-04 | 161 | 42 | 3 | a480107b1c7773f2081afca2657e0b7fc88a5645 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-epithelial_progenitor_cell-Stem_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.75e-04 | 162 | 42 | 3 | 472194eccc29c905010e2d8faa67c1a07d5e7118 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-04 | 163 | 42 | 3 | 2a561aa4518cf52d8470eff083b84f942a2b2b5d | |
| ToppCell | 356C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.92e-04 | 164 | 42 | 3 | b3192c443f4848e6a8afdb89c155f9ec42a154b0 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-MEP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.92e-04 | 164 | 42 | 3 | 47355439e578d1b1a387fb4ee761162028abea4a | |
| ToppCell | 356C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.92e-04 | 164 | 42 | 3 | f7288ec4daf494dae770ea6c58bead27660ccae1 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_NK-NK_CD56bright_CD16-|GI_small-bowel / Manually curated celltypes from each tissue | 4.92e-04 | 164 | 42 | 3 | 36e64e4f717dd59b352c20ff9742ca1e232342bb | |
| ToppCell | Multiple_Sclerosis-Other-HSPC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 4.92e-04 | 164 | 42 | 3 | 6af5529507d695b347adee4be5ead70f56c9cf55 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 5.01e-04 | 165 | 42 | 3 | 7b992843bd8ef92a7a76b1d681fa84efde6f5bdd | |
| Drug | nitrofen | 1.81e-05 | 87 | 41 | 4 | CID000015787 | |
| Drug | Ajmaline [4360-12-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 2.68e-05 | 197 | 41 | 5 | 7484_UP | |
| Drug | Allantoin [97-59-6]; Down 200; 25.2uM; PC3; HT_HG-U133A | 2.75e-05 | 198 | 41 | 5 | 1800_DN | |
| Drug | Evoxine [522-11-2]; Up 200; 11.6uM; PC3; HT_HG-U133A | 2.75e-05 | 198 | 41 | 5 | 7380_UP | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 2.88e-05 | 200 | 41 | 5 | 2323_DN | |
| Disease | leukemia (implicated_via_orthology) | 2.38e-06 | 19 | 41 | 3 | DOID:1240 (implicated_via_orthology) | |
| Disease | medulloblastoma (is_implicated_in) | 8.42e-05 | 10 | 41 | 2 | DOID:0050902 (is_implicated_in) | |
| Disease | Myopia | 1.96e-04 | 15 | 41 | 2 | C0027092 | |
| Disease | obesity (is_marker_for) | 3.78e-04 | 101 | 41 | 3 | DOID:9970 (is_marker_for) | |
| Disease | diet measurement, fasting blood insulin measurement | 4.28e-04 | 22 | 41 | 2 | EFO_0004466, EFO_0008111 | |
| Disease | diet measurement, HOMA-IR | 4.68e-04 | 23 | 41 | 2 | EFO_0004501, EFO_0008111 | |
| Disease | fatty liver disease (biomarker_via_orthology) | 9.68e-04 | 33 | 41 | 2 | DOID:9452 (biomarker_via_orthology) | |
| Disease | Squamous cell carcinoma of the head and neck | 2.39e-03 | 52 | 41 | 2 | C1168401 | |
| Disease | Mouth Neoplasms | 2.58e-03 | 54 | 41 | 2 | C0026640 | |
| Disease | Malignant neoplasm of mouth | 2.58e-03 | 54 | 41 | 2 | C0153381 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ICFSLFRRRRERRTL | 96 | Q9UK96 | |
| RCRDYRLRLARSTLT | 331 | P48546 | |
| RRSSARSLQHLCRLV | 216 | Q9NSE2 | |
| RHRRGCRLRDLLDIA | 646 | Q6ZPD9 | |
| RRGLLLCLRHIAALR | 211 | Q96MI9 | |
| ALRSRAALRALRLRC | 61 | Q32P28 | |
| ERLRRRIELCRRHHS | 21 | Q92585 | |
| TRRERRRLLRTCVDF | 161 | Q2VYF4 | |
| RSEALLHSLRRSRRV | 81 | Q92886 | |
| LKTLRLRLRRCHRFL | 116 | P22301 | |
| IRRCTVLRDARIRSH | 286 | Q9Y5P6 | |
| TRRRRIEIAHALCLS | 221 | P20719 | |
| RRRLSKLRTRHCTQA | 411 | E9PQR5 | |
| RRLRRLPSAVCALSR | 31 | A6NIK2 | |
| VHLRDRALSCRLRLR | 151 | P18627 | |
| LRSHRRLREIRTRCA | 71 | Q8IVL5 | |
| RRRRRDLLLSQLCFL | 16 | Q9HC58 | |
| RRRRIEIAHALCLSE | 221 | P09067 | |
| LTRRRRIEIAHALCL | 171 | P17509 | |
| RRRRIEIAHTLCLSE | 181 | P09016 | |
| LTRRRRIEIAHSLCL | 181 | P09017 | |
| TRRRRIEIAHTLCLS | 241 | Q00056 | |
| TRRRRIEIAHALCLT | 156 | P31268 | |
| RRRRCELRSLAHTLL | 391 | P0CW18 | |
| RLRRLDLAACRLFSV | 136 | Q9GZU5 | |
| LLNILRHCRRLSEVR | 231 | Q96BD8 | |
| AASCARHRRSLRLLE | 101 | Q8WUY1 | |
| RKFSRLSCLRRRRHP | 451 | Q9UPR3 | |
| ILHVECRARRRQRSA | 221 | Q96AM1 | |
| HSCILEKRLLRRSRS | 226 | P85299 | |
| SLDLRRRHCQRLDVL | 551 | Q9Y6C5 | |
| RLASRCRDARIRLLL | 491 | Q8NG04 | |
| DLIRRLICSREHRLG | 316 | Q5VT25 | |
| LGRSRLTHICRADLR | 971 | Q92502 | |
| TRTHQLLDRSLRRRA | 1051 | P36956 | |
| RRERLQEHLRLCQLR | 1686 | O15020 | |
| HSSSLLRCVRRRRRR | 116 | Q0P670 | |
| RRDALLHCLTTSRAR | 161 | Q6P1M0 | |
| LTLVCIRRSCLHRRR | 781 | P35590 | |
| VISHLRLLLRQLCRR | 1081 | Q8TD43 | |
| SRRLALLERRRILAH | 736 | Q6EMB2 | |
| IARLRHIKRLRQRIC | 1741 | P49815 | |
| ELCRRRSLLELHKRR | 131 | P53350 |